Research output per year
Research output per year
Fingerprint
Dive into the research topics where Steven Kemp is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
Cellular Models of Aggregation-Dependent Template-Directed Proteolysis to Characterize Tau Aggregation Inhibitors for Treatment of Alzheimer's Disease
Harrington, C. R., Storey, J. M. D., Clunas, S., Harrington, K. A., Horsley, D., Ishaq, A., Kemp, S. J., Larch, C. P., Marshall, C., Nicoll, S. L., Rickard, J. E., Simpson, M., Sinclair, J. P., Storey, L. J. & Wischik, C. M., 24 Apr 2015, In: The Journal of Biological Chemistry. 290, 17, p. 10862-10875 14 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile94 Link opens in a new tab Citations (Scopus)24 Downloads (Pure) -
Methods of chemical synthesis of diaminophenothiazinium compounds involving the use of persulfate oxidants
Larch, C. P. (Inventor), Storey, J. M. D. (Inventor), Williamson, C. (Inventor), Marshall, C. (Inventor) & Kemp, S. J. (Inventor), 8 Mar 2012, IPC No. AA61K315415FI , Patent No. 20120058995Research output: Patent
-
Ligands for aggregated tau molecules: WO2010034982
Kemp, S. J. (Inventor), Storey, J. M. D. (Inventor), Rickard, J. E. (Inventor), Harrington, C. R. (Inventor), Horsley, D. (Inventor), Wischik, C. M. (Inventor), Clunas, S. (Inventor) & Heinrich, T. (Inventor), 1 Apr 2010, Patent No. WO2010/034982Research output: Patent
File32 Downloads (Pure) -
New tetrahydro-1,2,4,5-tetrazinan-3-ones and oxoverdazyl free radicals
Plater, M. J., Sinclair, J. P., Kemp, S., Gelbrich, T., Hursthouse, M. B. & Gómez-García, C. J., 1 Aug 2006, In: Journal of Chemical Research. 8, 8, p. 515-520 6 p.Research output: Contribution to journal › Article › peer-review
12 Link opens in a new tab Citations (Scopus) -
A stable oxoverdazyl free radical: Structural and magnetic characterization
Plater, M. J., Kemp, S., Coronado, E., Gomez-Garcia, C. J., Harrington, R. W. & Clegg, W., Aug 2006, In: Polyhedron. 25, 12, p. 2433-2438 6 p.Research output: Contribution to journal › Article
13 Link opens in a new tab Citations (Scopus)
Impacts
-
Discovery and commercialisation of an entirely new drug for the treatment of Alzheimer's disease
Wischik, C. (Participant), Harrington, C. (Participant), Storey, J. (Participant), Rickard, J. (Participant), Horsley, D. (Participant), Baddeley, T. (Participant), Kemp, S. (Participant), Sinclair, J. (Participant), Zabke, C. (Participant), Theuring, F. (Participant), Stamer, F. (Participant) & Marshall, C. (Participant)
Impact: Health and Wellbeing, Economic and/or Commercial